ICICI Prudential Mutual Fund decreased its stake in Camlin Fine Sciences from 4.80% to 4.77%, selling 62,690 shares worth ₹76.90 lakh.
A specialty chemicals manufacturer based in India, Camlin Fine Sciences produces high-performance chemical products for diverse industrial applications including pharmaceuticals, agrochemicals, and performance chemicals. The company serves customers across domestic and international markets through its integrated manufacturing facilities. Its focus on research-driven product development and technical expertise in specialty chemical synthesis distinguishes it within the competitive chemicals sector.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.
